<table id="TableV" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>TABLE V Lipid-lowering Effects of Lovastatin in Adolescent Boys with Heterozygous Familial Hypercholesterolemia (Mean Percent Change from Baseline at Week 48 in Intention-to-Treat Population)</caption>
<col align="left" valign="bottom" width="15%"></col>
<col align="center" valign="bottom" width="14%"></col>
<col align="center" valign="bottom" width="14%"></col>
<col align="center" valign="bottom" width="14%"></col>
<col align="center" valign="bottom" width="14%"></col>
<col align="center" valign="bottom" width="14%"></col>
<col align="center" valign="bottom" width="15%"></col>
<thead>
<tr>
<th valign="bottom">DOSAGE</th>
<th valign="bottom">N</th>
<th valign="bottom">TOTAL-C</th>
<th valign="bottom">LDL-C</th>
<th valign="bottom">HDL-C</th>
<th valign="bottom">TG.<footnote>data presented as median percent changes</footnote>
</th>
<th valign="bottom">Apolipoprotein B</th>
</tr>
</thead>
<tbody>
<tr>
<td>Placebo</td>
<td>61</td>
<td>–1.1</td>
<td>–1.4</td>
<td>–2.2</td>
<td>–1.4</td>
<td>–4.4</td>
</tr>
<tr>
<td>Lovastatin</td>
<td>64</td>
<td>–19.3</td>
<td>–24.2</td>
<td>+1.1</td>
<td>–1.9</td>
<td>–21</td>
</tr>
</tbody>
</table>